- Report
- May 2024
- 226 Pages
Global
From €3384EUR$3,850USD£2,927GBP
€4263EUR$4,850USD£3,687GBP
- Report
- August 2024
- 170 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- August 2022
- 118 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- October 2023
- 113 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- August 2022
- 115 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- August 2022
- 116 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- October 2021
- 100 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- December 2021
- 163 Pages
Global
From €3911EUR$4,450USD£3,383GBP
- Report
- July 2024
- 100 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- July 2024
- 150 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- July 2024
- 150 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- July 2024
- 100 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3076EUR$3,500USD£2,661GBP
- Report
- December 2024
- 85 Pages
India
From €3076EUR$3,500USD£2,661GBP
- Report
- July 2024
- 150 Pages
Global
From €3296EUR$3,750USD£2,851GBP
- Report
- January 2024
- 200 Pages
Global
From €3648EUR$4,150USD£3,155GBP
- Report
- January 2024
- 200 Pages
Global
From €3648EUR$4,150USD£3,155GBP
- Report
- September 2024
- 142 Pages
Global
From €2636EUR$2,999USD£2,280GBP
- Report
- February 2024
- 186 Pages
Global
From €3955EUR$4,500USD£3,421GBP
- Report
- December 2024
- 80 Pages
India
From €3076EUR$3,500USD£2,661GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more